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In this paper we report an IC50 value for 1,6-epi-cyclophellitol(compound 7, JJB307) as a human lysosomal α-glucosidase
(GAA) inhibitor of 54.1 ± 4.9 nM in vitro and 97.6 ± 14.5 nM
in situ (Figure 3a). We re-evaluated these data and now find
that compound 7 is actually a low micromolar GAA inhibitor
with an IC50 of 14.6 ± 1.6 μM in vitro and >50 μM in situ.
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